EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The potential significance of hepcidin evaluation in progressive supranuclear palsy

Piotr Alster iD, Dagmara Otto-Ślusarczyk, Alicja Wiercińska-Drapało, Marta Struga, Natalia Madetko-Alster

Brain and Behavior · 2024-06 · 14 (6)

DOI: 10.1002/brb3.3552 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain and Behavior, online erschienen am 21.06.2024. Verfasst von Piotr Alster und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Medical University of Warsaw, Warsaw, Poland. Hauptthemen laut MEDLINE: Hepcidins, Supranuclear Palsy, Progressive. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Warszawski Uniwersytet Medyczny.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Hepcidin is a peptide associated with controlling the distribution of iron in tissues. Growing interest is linked with its impact on neurodegenerative diseases, as disruption of the iron regulation may be considered an initiatory element of pathological protein accumulation. The possible impact of hepcidin was not previously sufficiently explored in progressive supranuclear palsy (PSP).

Methods

Twelve patients with PSP–Richardson's syndrome (PSP–RS), 12 with PSP‐Parkinsonism Predominant (PSP‐P), and 12 controls were examined using Unified Parkinson's Disease Rating Scale—III part (UPDRS‐III) in OFF stage and analyzed in the context of hepcidin levels in the serum.

Results

The work revealed increased levels of hepcidin in PSP–RS when compared to PSP‐P and controls. Moreover, hepcidin was found to be negatively correlated with UPDRS‐III results in PSP–RS, whereas positively in PSP‐P.

Conclusion

The work may suggest a possible impact of hepcidin in PSP, possibly differing depending on its subtype.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HepcidinsSupranuclear Palsy, ProgressiveAgedFemaleHumansMaleMiddle AgedSeverity of Illness Index

Stichwörter der Autor:innen

PSPatypical parkinsonismhepcidinprogressive supranuclear palsy

Substanzen

HepcidinsHAMP protein, human

Autor:innen und Institutionen

  • Department of Neurology, Medical University of Warsaw, Warsaw, Poland.
  • Department of Biochemistry, Medical University of Warsaw, Warsaw, Poland.
  • Department of Infectious and Tropical Diseases and Hepatology, Medical University of Warsaw, Warsaw, Poland.

ORCID-Profile: Piotr Alster

Förderung

  • Warszawski Uniwersytet Medyczny

Zitieren

APA

Alster, P., Otto-Ślusarczyk, D., Wiercińska-Drapało, A., Struga, M., & Madetko-Alster, N. (2024). The potential significance of hepcidin evaluation in progressive supranuclear palsy. Brain and Behavior, 14(6). https://doi.org/10.1002/brb3.3552

Vancouver

Alster P, Otto-Ślusarczyk D, Wiercińska-Drapało A, Struga M, Madetko-Alster N. The potential significance of hepcidin evaluation in progressive supranuclear palsy. Brain and Behavior. 2024;14(6). doi:10.1002/brb3.3552

BibTeX
@article{Alster2024,
  author = {Alster, Piotr and Otto-Ślusarczyk, Dagmara and Wiercińska-Drapało, Alicja and Struga, Marta and Madetko-Alster, Natalia},
  title = {The potential significance of hepcidin evaluation in progressive supranuclear palsy},
  journal = {Brain and Behavior},
  year = {2024},
  volume = {14},
  number = {6},
  doi = {10.1002/brb3.3552}
}
Kostenlos starten →